<SEC-DOCUMENT>0001104659-25-072162-index.html : 20250730
<SEC-HEADER>0001104659-25-072162.hdr.sgml : 20250730
<ACCEPTANCE-DATETIME>20250730161225
ACCESSION NUMBER:		0001104659-25-072162
CONFORMED SUBMISSION TYPE:	PREM14A
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20250910
FILED AS OF DATE:		20250730
DATE AS OF CHANGE:		20250730

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ESSA Pharma Inc.
		CENTRAL INDEX KEY:			0001633932
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		PREM14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37410
		FILM NUMBER:		251167171

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 720
		STREET 2:		999 WEST BROADWAY
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V5Z 1K5
		BUSINESS PHONE:		(778) 331-0962

	MAIL ADDRESS:	
		STREET 1:		SUITE 720
		STREET 2:		999 WEST BROADWAY
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V5Z 1K5
</SEC-HEADER>
<DOCUMENT>
<TYPE>PREM14A
<SEQUENCE>1
<FILENAME>tm2520986-4_prem14a.htm
<DESCRIPTION>PREM14A
<TEXT>
Document 1 - file: tm2520986-4_prem14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>tm2520986d4_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 2 - file: tm2520986d4_ex-filingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ft_leerinkpartners-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: ft_leerinkpartners-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_essa-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: lg_essa-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>lg_leerinkpartners-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: lg_leerinkpartners-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>px_essapharmaproxy1pg01-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: px_essapharmaproxy1pg01-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>px_essapharmaproxy1pg02-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: px_essapharmaproxy1pg02-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>px_essapharmaproxy1pg03-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: px_essapharmaproxy1pg03-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>px_essapharmaproxy1pg04-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: px_essapharmaproxy1pg04-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>px_essapharmaproxy1pg05-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: px_essapharmaproxy1pg05-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>px_essapharmaproxy1pg06-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: px_essapharmaproxy1pg06-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>sg_leerinkpartnersllc-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: sg_leerinkpartnersllc-bw.jpg

</DOCUMENT>
</SEC-DOCUMENT>